Morpholino

MO2-cmlc1

ID

ZDB-MRPHLNO-090527-1

Name

MO2-cmlc1

Previous Names

Target

Sequence

5' - TGCCATGATGCTGATGGGAAAAGGC - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO2-cmlc1

No data available

Phenotype

Phenotype resulting from MO2-cmlc1

Phenotype	Fish	Figures
atrioventricular canal GCaMP expression decreased amount, abnormal	ubs3Tg; zf350Tg + MO2-cmlc1	Fig. 4 from Heckel et al., 2015
cardiac ventricle sarcomere immature, abnormal	WT + MO2-cmlc1	Fig. 4 from Meder et al., 2009
cardiac ventricle striated muscle myosin thick filament absent, abnormal	WT + MO2-cmlc1	Fig. 4 from Meder et al., 2009
heart contraction disrupted, abnormal	WT + MO2-cmlc1	Fig. 4 from Meder et al., 2009
pericardium edematous, abnormal	WT + MO2-cmlc1	Fig. S4 from Bührdel et al., 2015 Fig. 4 from Meder et al., 2009
ventricular cardiac myofibril assembly process quality, abnormal	WT + MO2-cmlc1	Fig. 4 from Meder et al., 2009

Phenotype of all Fish created by or utilizing MO2-cmlc1

Phenotype	Fish	Conditions	Figures
cardiac ventricle sarcomere immature, abnormal	WT + MO2-cmlc1	standard conditions	Fig. 4 from Meder et al., 2009
ventricular cardiac myofibril assembly process quality, abnormal	WT + MO2-cmlc1	standard conditions	Fig. 4 from Meder et al., 2009
heart contraction disrupted, abnormal	WT + MO2-cmlc1	standard conditions	Fig. 4 from Meder et al., 2009
pericardium edematous, abnormal	WT + MO2-cmlc1	standard conditions	Fig. S4 from Bührdel et al., 2015 Fig. 4 from Meder et al., 2009
cardiac ventricle striated muscle myosin thick filament absent, abnormal	WT + MO2-cmlc1	standard conditions	Fig. 4 from Meder et al., 2009
atrioventricular canal GCaMP expression decreased amount, abnormal	ubs3Tg; zf350Tg + MO2-cmlc1	control	Fig. 4 from Heckel et al., 2015

Citations